Navigation Links
Mobile Catheterization Laboratories Serving Hospital Networks

ProductsMobile Catheterization Laboratories Serving Hospital Networks
Company MedCath Corporation
Item Mobile Catheterization Laboratories Serving Hospital Networks
Features Turnkey Service

With many years experience of opening and operating cath labs, MedCath can provide the expertise to setup and manage your cath lab program. Here are a few of the benefits of partnering with MedCath:

  • MedCath will leverage its extensive purchasing network to provide new, updated cath lab equipment at the lowest possible cost along with other necessary procedure supplies.
  • We ensure ongoing compliance with all state and federal regulations and applicable JCAHO standards.
  • The MedCath operating model ensures lower staffing cost through reduction in cath lab personnel and the use of shared resources with other MedCath owned/managed cath labs.
  • With over 50 cath labs that are MedCath owned or managed, we have the experience to design an efficient diagnostic facility, oversee construction, manage the installation of equipment, recruit, hire and train personnel and begin operations in a very timely manner.
Operational Support

MedCath supports the ongoing operations with constant review of and compliance with JCAHO and CLIA standards. Additionally, we collect and analyze clinical and financial outcome data that is presented to you on a quarterly basis. We provide marketing support to ensure patient/physician awareness of the benefits of the cath lab and increase your referral network. MedCaths constant focus on performance improvement ensures that your facility will provide the highest quality cardiac diagnostic services.

MedCath can also demonstrate the advantages of creating a diagnostic center with additional service capabilities. A multi-disciplinary center can open treatment options, increase efficiency and broaden your potential patient base. We are experienced developers and managers of:

  • Nuclear Cardiology Programs
  • Sleep Centers
  • Enhanced Counterpulsation (ECP) Centers
Description MedCath is the largest and most experienced provider of mobile catheterization services to hospital networks in the United States. Mobile laboratories serving hospital networks are moved, usually on a daily basis, from one hospital to another in a particular hospital network or geographic area. Each mobile laboratory is fully equipped and operated by MedCath medical technicians and nurses, which provide the hospital or physician group with a turn key catheterization laboratory. MedCath's mobile laboratories permit a group of hospitals located in geographic proximity to one another, each with limited cardiovascular patient volume, to offer cardiovascular services through shared access to equipment and personnel. This allows hospitals and physicians to offer cardiovascular care services while avoiding the substantial capital expenditures and operating expenses needed to purchase and operate the equipment required to perform these services.
Info MedCath Corporation
Customer Service: (704) 708-6600
Web site: http://www.medcath.com

Related medicine products :

1. Mobile Instrument Stand
2. Laserex Tango M (Total Mobile Version)
3. Reliance Mobile Surgical Stretcher
4. LCS Complete Mobile-Bearing Knee System
5. XiScan 6000™ Mobile Fluoroscopic C-Arm
6. MiniView 6800 Digital Mobile C-Arm
7. CardioNet: Mobile Outpatient Cardiac Telemetry
8. Mobile Protective Shield
9. Height-Adjustable Mobile X-Ray Barrier
10. Adjustable Mobile Shield
11. Mobile Barrier
...ly invasive surgery is founded on superior medical...-Chip cameras, 1-Chip cameras, Light sources, Coup...nding needs., ,Superior resolution and color repr...meras, and are the benchmark by which all other me...
...ra System provides easy-to-use features, auto iris...amera head construction is based on Solos durable ...era System, International (GS9900-PAL) includes: ,...rd and video cables , (GS 9905) Camera head with 3...
Provides a combination of concentrated cold / hot and compression for the elbow
Provides extended cold therapy for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and speed recovery.
Medicine Products:
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...eld at the Grampians Community Health Centre has m...r drugs //. Educating people about the adverse e...arried out by the GCH center. Problems related t...amilial and community factors all in some way happ...
Drug - resistant microbes raise concerns
...rds and Primary Health Organisations, (PHOs), whic...en resolved //, with both parties reaching an agr... visits. An estimated 680,000 New Zealanders who ... 45 - 64 years, are expected to benefit from July ...
... reported that two tourists have contracted malari... that the recent outbreak //of malaria on the isla...ndustry. The tourists, a Canadian and an American...fter visiting Great Exuma. The Public Health Agen...
Other Medicine News:Health News:Drug - resistant microbes raise concerns 2Health News:Outbreak of Malaria to Lead to Loss in Tourist Industry 2
(Date:10/8/2008)...tute Pioneers Research That May Offer New Hope to,...re/ -- Nationally, over 3,000 people are,waiting f...adly, only half,of those will receive a transplant...ute (AHI) is paving the way for how to treat conge...Multimedia News Release, go to:, http://www.prnews...
(Date:10/8/2008)...m to evaluate TAXUS(R) Element(TM) Platinum Chromi... Mass., Oct. 8 /- Boston Sc... that it has completed enrollment in,the PERSEUS t...eration,TAXUS(R) Element(TM) paclitaxel-eluting co...olled nearly 1,500 patients at 100 U.S. and,intern...
(Date:10/8/2008)...y shows clinical improvement in patients with pulm...ent treatment options have limited benefit for thi...able blood vessel disease, -- Imatinib mesylate... cancers, known to inhibit protein associated...tial of imatinib mesylate in PAH in 2009 EAS...
(Date:10/7/2008)...icacy of new device for detecting polyps that can ..., ORLANDO, Fla., Oct. 7 /- At the Am...ic Meeting in Orlando (ACG 2008), renowned,gastroe...rom a,multi-institutional clinical study that eval...R), a new device that is designed to improve the a...
Breaking Medicine Technology:Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Dallas area cornea shortages could benefit from national study 15643 1Dallas area cornea shortages could benefit from national study 15643 2Dallas area cornea shortages could benefit from national study 15643 3Agendia Appoints Oncologist Richard A Bender as Vice President and Chief Medical Officer 15641 1Agendia Appoints Oncologist Richard A Bender as Vice President and Chief Medical Officer 15641 2Agendia Appoints Oncologist Richard A Bender as Vice President and Chief Medical Officer 15641 3Stroke Patients Re Learn to Walk Correctly Again Using Special Treadmill 15638 1Stroke Patients Re Learn to Walk Correctly Again Using Special Treadmill 15638 2Minnesotans Demonstrate Commitment to Organ and Tissue Donation 15635 1Minnesotans Demonstrate Commitment to Organ and Tissue Donation 15635 2
...atients treated with,Exforge achieved recommended ...ease of 20 mmHg in,systolic blood pressure observe...with previous monotherapy[1] , Nearly 70% of thos... levels[2] and most require two or more,medication... May 21, 2007 - Exforge®,a single-tablet comb...
...URETIC ACCEPTED FOR REVIEW BY,FDA- , BASEL, Switze...(SWX: SPPN) today welcomed the significant new res...kturna/Rasliez[1]),presented by investigators at t...f the American Society of Hypertension (ASH) in,Ch...le safety and,efficacy profile, as well as the pot...
Other Medicine Technology:Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 2Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 3Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 5Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 6Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 7Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 2New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 3New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 4New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 5New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 7New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 9New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 10New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 11